Childhood Reactive Thrombocytosis
NCT01230528 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2010-10-29
Summary
Reactive thrombocytosis (RT) in pediatric patients is common, but usually without symptoms. The incidence of RT is different depending on age. Mostly, we reasoned that RT is a phenomenon, nevertheless the diagnostic value of RT is little known. Therefore, the aim of this study was to determine the association of RT and clinical or laboratory characteristics in pediatric diseases.
Conditions
- Reactive Thromobocytosis in Children
Sponsors & Collaborators
-
Taipei Medical University WanFang Hospital
lead OTHER
Principal Investigators
-
Jinn-Li Wang · Taipei Medical University WanFang Hospital
Eligibility
- Min Age
- 1 Day
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2010-01-31
- Completion
- 2010-06-30
Countries
- Taiwan
Study Locations
More Related Trials
-
Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
NCT00331357 ·Status: UNKNOWN
-
The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids
NCT06568913 ·Status: RECRUITING ·Phase: NA
-
Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP
NCT05846529 ·Status: UNKNOWN
-
Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia
NCT01672151 ·Status: COMPLETED
-
"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"
NCT07014904 ·Status: NOT_YET_RECRUITING
-
Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia
NCT06281327 ·Status: RECRUITING ·Phase: PHASE2
-
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06168851 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura (Kid's ITP Tools)
NCT03123497 ·Status: UNKNOWN
-
Study of T Cells and Natural Killer Cells Expression in Patients With Immune Thrombocytopenic Purpura
NCT05093257 ·Status: UNKNOWN
-
Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.
NCT04070599 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Markers in Pediatric ITP on Second Line Therapy
NCT06093529 ·Status: NOT_YET_RECRUITING
-
IL37,Tlymphocytes,NK Cells in Pathogenesis of ITP
NCT04482777 ·Status: UNKNOWN
-
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
NCT00454857 ·Status: COMPLETED
-
Clinical Pattern of Glanzemnn Thrombathenia in Children Attending Assiut University Children Hospital
NCT06753188 ·Status: NOT_YET_RECRUITING
-
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
NCT05520892 ·Status: RECRUITING ·Phase: PHASE4
-
Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)
NCT06838962 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia
NCT01668615 ·Status: COMPLETED
-
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP
NCT03377439 ·Status: UNKNOWN
-
Research of Predictive Factors to Immune Thrombopenic Purpura
NCT01648556 ·Status: COMPLETED ·Phase: NA
-
NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults
NCT01172015 ·Status: COMPLETED ·Phase: NA
-
ADAMTS13 in Thrombotic Thrombocytopenic Purpura
NCT00426686 ·Status: COMPLETED
-
Eltrombopag in Chronic ITP
NCT04102033 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura
NCT02317133 ·Status: COMPLETED
-
Short-course High-dose Prednisone and Dexamethasone in Children With ITP
NCT05522465 ·Status: RECRUITING ·Phase: PHASE4
-
Diagnostic of Chronic Thrombocytopenia
NCT04071496 ·Status: COMPLETED